Xiang Yang Lu
Amministratore Delegato presso LAEKNA, INC.
Patrimonio netto: 43 M $ in data 31/05/2024
Posizioni attive di Xiang Yang Lu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LAEKNA, INC. | Amministratore Delegato | 29/07/2016 | - |
| Presidente | 29/07/2016 | - | |
| Fondatore | 29/07/2016 | - | |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 01/12/2016 | - | |
| Fondatore | 01/12/2016 | - | |
| Laekna Ltd. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Xiang Yang Lu
Precedenti posizioni note di Xiang Yang Lu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| China Novartis Institutes for BioMedical Research Co., Ltd. | Direttore/Membro del Consiglio | 01/09/2003 | 01/03/2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/09/2003 | 01/03/2016 |
| Frontline Bioventures | Corporate Officer/Principal | 01/01/2016 | - |
Formazione di Xiang Yang Lu
| Nankai University | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Statistiche
Distribuzione geografica
| Cina | 6 |
| Stati Uniti | 3 |
| Hong Kong | 2 |
Posizioni
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LAEKNA, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Health Technology |
| Frontline Bioventures | Finance |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Laekna Ltd. | |
| China Novartis Institutes for BioMedical Research Co., Ltd. |
- Borsa valori
- Insiders
- Xiang Yang Lu
- Esperienza
